Yong-Jiang Xu | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Yong-Jiang Xu is active.

Explore More

Publication

Featured researches published by Yong-Jiang Xu.

Synthetic Communications | 2006

Efficient Preparation of ((3‐Chloro‐2‐fluoro‐phenyl)‐[7‐methoxy‐8‐(3‐morpholin‐4‐yl‐propoxy)‐10,11‐dihydro‐5‐oxa‐2,4,11‐triaza‐dibenzo(a,d)cyclohepten‐1‐yl]‐amine) for In‐Vivo Study

Hu Liu; Leon M. Smith; Yunyu Mao; Weitao Pan; Yong-Jiang Xu; Sabina Burdzovic-Wizeman; Matthew Duncton; Wai C. Wong

Abstract An improved route for the preparation of highly functionalized 5,6‐dihydro‐pyrimido[4,5‐b][1,4]oxazepine 1a in multigram quantities was developed. This new methodology was highlighted by the proper methoxy disposition via a regioselective methylation of 2,4,5‐trihydroxy‐benzaldehyde followed by a magnesium sulfate–promoted cyclization.

Bioorganic & Medicinal Chemistry Letters | 2006

1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors.

Weitao Pan; Hua-Quan Miao; Yong-Jiang Xu; Elizabeth Navarro; James R. Tonra; Erik Corcoran; Armin Lahiji; Paul Kussie; Alexander S. Kiselyov; Wai C. Wong; Hu Liu

Bioorganic & Medicinal Chemistry Letters | 2005

Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases.

Weitao Pan; Hu Liu; Yong-Jiang Xu; Xin Chen; Ki Kim; Daniel L. Milligan; John Columbus; Yaron R. Hadari; Paul Kussie; Wai C. Wong; Marc Labelle

Bioorganic & Medicinal Chemistry Letters | 2006

Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase

Leon M. Smith; Wai C. Wong; Alexander S. Kiselyov; Sabina Burdzovic-Wizemann; Yunyu Mao; Yong-Jiang Xu; Matthew Duncton; Ki Kim; Evgueni Piatnitski; Jacqueline F. Doody; Ying Wang; Robin L. Rosler; Daniel L. Milligan; John Columbus; Chris Balagtas; Sui Ping Lee; Andrey Konovalov; Yaron R. Hadari

Bioorganic & Medicinal Chemistry Letters | 2006

N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors.

Yong-Jiang Xu; Hua-Quan Miao; Weitao Pan; Elizabeth Navarro; James R. Tonra; Stan Mitelman; Margarita Camara; Dhanvanthri S. Deevi; Alexander S. Kiselyov; Paul Kussie; Wai C. Wong; Hu Liu

Tetrahedron Letters | 2007

Synthesis of unsymmetrical and regio-defined 2,3,6-quinoxaline and 2,3,7-pyridopyrazine derivatives

Dan Sherman; Joel Kawakami; Hai-Ying He; Farah Dhun; Raphael Rios; Hu Liu; Weitao Pan; Yong-Jiang Xu; Sang-phyo Hong; Melissa Arbour; Marc Labelle; Matthew Duncton

Bioorganic & Medicinal Chemistry Letters | 2006

Tricyclic azepine derivatives: Pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors

Leon M. Smith; Evgueni Piatnitski; Alexander S. Kiselyov; Xiaohu Ouyang; Xiaoling Chen; Sabina Burdzovic-Wizemann; Yong-Jiang Xu; Ying Wang; Robin L. Rosler; Sheetal Patel; Hui-Hsien Chiang; Daniel L. Milligan; John Columbus; Wai C. Wong; Jacqueline F. Doody; Yaron R. Hadari

Tetrahedron Letters | 2005